Jennifer Ann Domm MD
Assistant Professor, Pediatrics, Vanderbilt University School of Medicine
Join to View Full Profile
330 23rd Ave NSuite 450Nashville, TN 37203
Phone+1 615-342-7339
Fax+1 615-342-7340
Dr. Domm is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterResidency, Pediatrics, 2000 - 2003
Vanderbilt University School of MedicineClass of 2000
Certifications & Licensure
TN State Medical License 2004 - 2026
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders Start of enrollment: 2009 Jul 31
- A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- Best Practices in Gene Therapy for Sickle Cell Disease and Transfusion-dependent β-Thalassemia.Haydar Frangoul, Amanda Stults, Katie Bruce, Jennifer Domm, Clinton Carroll
Transplantation and Cellular Therapy. 2025-03-07 - 557 citationsCRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.Haydar Frangoul, David Altshuler, M Domenica Cappellini, Yi-Shan Chen, Jennifer Domm
The New England Journal of Medicine. 2021-01-21 - 15 citationsHaploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy ...Haydar Frangoul, Misty Evans, Julie Isbell, Katie Bruce, Jennifer Domm
Bone Marrow Transplantation. 2018-01-16
Journal Articles
- CRISPR-Cas9 Gene Editing for Sickle Cell Disease and Β-thalassemiaHaydar Frangoul, Jennifer Domm, Stephan Grupp, Rupert Handgretinger, The New England Journal of Medicine
Press Mentions
CRISPR Technology to Cure Sickle Cell DiseaseJanuary 20th, 2021
Watch as a 4-Year-Old Boy Fighting Cancer Gets His First Hearing AidsSeptember 30th, 2019
Simulation Program Helps Doctors Prepare for Difficult Talks with PatientsJune 28th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
